Our Trip to the Grand Canyon to Raise Money for Cancer Research

Boruzu, an injectable presentation of Velcade, has been approved by the FDA for patients who either have multiple myeloma or mantle cell lymphoma.

From FDA concerns to a potential new drug, CAR-T cell therapies were dominating oncology headlines last week.

CAR-T cell therapy is moving to earlier lines of multiple myeloma treatment.

In this episode of the “Cancer Horizons” podcast, a physician assistant recalls his experience as a frontline health care worker during the COVID-19 pandemic and what it was like to get diagnosed with multiple myeloma during such a chaotic time.

Patients with multiple myeloma now have several available treatment options, so it’s important to have answers to some of the frequently asked questions.

I was diagnosed with stage 1 multiple myeloma in 2018 and writing poetry helped me work through feelings of anger and acceptance.